000			02105nam a22002777a 4500
001			D0001C000087
003			DOH
005			20210109104153.0
008			210109b ||||| |||| 00| 0 eng d
245	0	0	_aUP Philippine General Hospital Division of Endocrinology, diabetes & metabolism consensus recommendations for in-patient management of diabetes mellitus among persons with COVID-19 / _bCecilia Jimeno [and seven others]
520	3		_aDiabetes mellitus (DM) is a known risk factor for morbidity and mortality among patients with COVID-19 based on recent studies. While there are many local and international guidelines on inpatient management of diabetes, the complicated pathology of the virus, the use of glucose-elevating drugs such as glucocorticoids, antivirals and even inotropes, and various other unique problems has made the management of in-hospital hyperglycemia among patients with COVID-19 much more difficult than in other infections. The objective of this guidance is to collate and integrate the best available evidence that has been published regarding in-patient management of diabetes among patients with COVID-19. A comprehensive review of literature was done and recommendations have been made through a consensus of expert endocrinologists from the University of the Philippines-Philippine General Hospital (UP-PGH) Division of Endocrinology, Diabetes and Metabolism. These recommendations are evolving as we continue to understand the pathology of the disease and how persons with diabetes are affected by this virus.
580			_aIn: JAFES 2020; vol. 35 (1) pages: 14-25
650		2	_aCOVID-19
650		2	_aDiabetes Mellitus
653			_aIn-patient Management
700	1		_aJimeno, Cecilia
700	1		_aAnonuevo-Cruz, Ma. Cecille
700	1		_aBea Uy, Angelique
700	1		_aBacena, Adrian Oscar
700	1		_aFrancisco, Mark David
700	1		_aTiglao-Gica, Angelique Love
700	1		_aBruno, Racquel
700	1		_aCorpuz, Diane Grace
856			_uhttps://www.asean-endocrinejournal.org/index.php/JAFES/article/view/821
942			_cCV
999			_c2321 _d2321